SCHEMBL3553775

SCHEMBL3553775

Cc1[nH]c2c(Br)cc(Cl)cc2c1OCCN(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
HRH3 Q9Y5N1 2/20 0.40
KDM4E B2RXH2 7/20 0.38
ALDH1A1 P00352 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
HTR7 P34969 2/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
HTR2B P41595 1/20 0.36
HTR6 P50406 1/20 0.36
MAOA P21397 1/20 0.34
ATM Q13315 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561474 0.86 MAPT (0.46) MAPTKDM4EALDH1A1TDP1CHRNB2
SCHEMBL3559067 0.86 KDM4E (0.40) MAPTHRH3KDM4EALDH1A1TDP1
SCHEMBL3564100 0.81 HTR7 (0.40) MAPTHRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL3563207 0.76 HTR7 (0.60) MAPTALDH1A1CHRNB2CHRNA4HTR7
SCHEMBL3563397 0.75 MAPT (0.45) MAPTHRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL3563997 0.73 ADRA2A (0.50) MAPTKDM4ESMN1; SMN2CHRNB2CHRNA4
SCHEMBL3564365 0.70 SLC6A4 (0.43) MAPTKDM4EALDH1A1HTR7ADRA2A
SCHEMBL14953563 0.69 KDM4E (0.42) MAPTHRH3KDM4EALDH1A1TDP1
SCHEMBL3462124 0.68 ADRA2A (0.45) MAPTKDM4EALDH1A1SMN1; SMN2CHRNB2
SCHEMBL4929003 0.68 MAPT (0.50) MAPTHRH3KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT MAPT 1145/4885HRH3 1087/4885KDM4E 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.